Topics
Assigned by weighted keyword evidence, not by a model — so the tagging is auditable, and broad topics over-fire. Use them to narrow a search, never as a finding in themselves.
| Topic | What it covers | Documents |
|---|---|---|
| Intelligence community assessments | Involvement of intelligence agencies, classified assessments and ODNI. | 1,999 |
| Vaccines | Vaccine development, trials, authorization, mandates and hesitancy. | 1,504 |
| Gates Foundation involvement | Bill & Melinda Gates Foundation funding, partnership and influence. | 864 |
| Media strategy and public messaging | Press strategy, interviews, op-eds and coordination of public communications. | 651 |
| Awards, honoraria and recognition | Prizes, awards, speaking fees and honors. | 550 |
| WHO and international investigation | World Health Organization involvement and international origin probes. | 530 |
| Wuhan Institute of Virology collaboration | Work with, funding of, or data from the Wuhan Institute of Virology. | 462 |
| Natural origin / zoonotic spillover | Discussion of natural spillover, wet markets and intermediate hosts. | 441 |
| Congressional oversight | Subpoenas, hearings, testimony and committee correspondence. | 429 |
| EcoHealth Alliance funding and grants | NIH/NIAID grants and subawards to EcoHealth Alliance and its partners. | 416 |
| Furin cleavage site and molecular features | Technical discussion of the furin cleavage site, receptor binding domain and other genomic features. | 394 |
| Lab-leak / accidental release hypothesis | Discussion of COVID-19 originating from a laboratory accident or leak. | 391 |
| Therapeutics and treatments | Drug treatments and clinical management of COVID-19. | 300 |
| Testing and surveillance | Diagnostic testing capacity, surveillance and case data. | 235 |
| Masks, lockdowns and NPIs | Non-pharmaceutical interventions: masking, distancing, closures. | 230 |
| Gain-of-function research | Gain-of-function experiments, dual-use research of concern and the P3CO review framework. | 225 |
| Proximal Origin paper | Drafting, review and publication of the 'Proximal Origin of SARS-CoV-2' paper and related messaging. | 187 |
| Biosafety and biosecurity | Laboratory biosafety levels, containment practices and lab incidents. | 176 |
| China relations and data access | Cooperation with, or obstruction by, Chinese authorities and access to Chinese data. | 160 |
| FOIA, records and transparency | Freedom of Information Act requests, records retention, deletion and attempts to avoid disclosure. | 112 |
| Monkeypox sample smuggling case | The Rocky Mountain Laboratories monkeypox sample importation case. | 75 |
| Public comments and policy process | Handling of public comments in federal policy rulemaking. | 65 |